ATN BOARD OF DIRECTORS

ATN�s overall program coordination is governed by a Board of Directors.  Members currently on the board include:

Margaret L. Bauman, MD
Medical Chair, ATN

 Associate Clinical Professor of Neurology, Harvard Medical School; Associate Pediatrician and Assistant Neurologist, Massachusetts General Hospital, Director of LADDERS (Learning  and Developmental Disabilities Evaluation and Rehabilitation Service) which is a satellite clinic of the MassGeneral Hospital for Children, and a branch of which is located at Giant Steps Connecticut in Southport, CT. Director, The Autism Research Foundation, Boston, MA and the Autism Research Consortium.  Adjunct Associate Professor, Department of Anatomy and Neurobiology, Boston University School of Medicine, Boston, MA. Staff neurologist, Casa Colina Centers for Rehabilitation, Inc, Pomona, California. Volunteer staff, Department of Pediatrics, University of California at Irvine, Irvine, California. Research interests include the study of the microscopic brain structure in autism, Rett syndrome and other disorders of neurological development. Co-editor of the book, "The Neurobiology of Autism" which was published in l994 by Johns Hopkins University Press. Second edition expected by November 2004.

Gleason Eakin
President, Northwest Autism Foundation

David K. Humphrey, JD

Mr. Humphrey is a board member of the Northwest Autism Foundation (NWAF) whose goal is to provide education and information about autism. For the past five years Mr. Humphrey has devoted much of his time to the research and study of autism, a growing global medical and health issue. He has visited other countries such as Thailand, China and North Korea to speak on the topic of autism. Mr. Humphrey is a successful entrepreneur who has founded several companies in Oregon and Hawaii. One of his companies was named for four consecutive years to Inc. magazine's prestigious list of "500 Fastest Growing Companies in the Nation."

James M. Perrin, M.D.
James M. Perrin, M.D., is professor of pediatrics at Harvard Medical School and director of the Division of General Pediatrics and the Center for Child and Adolescent Health Policy at the MassGeneral Hospital for Children, a research and training center with an active fellowship program in general pediatrics. He chaired the American Academy of Pediatrics Committee on Children with Disabilities and is past president of the Ambulatory Pediatric Association. For the American Academy of Pediatrics, he also co-chaired a committee to develop practice guidelines for attention deficit hyperactivity disorder. His research has examined asthma, middle ear disease, children's hospitalization, health insurance, and childhood chronic illness and disabilities, with a recent emphasis on quality of life and use of primary and subspecialty care for children and adolescents with chronic illness. Dr. Perrin is the founding editor of Ambulatory Pediatrics, the journal of the Ambulatory Pediatric Association. He served on the Institute of Medicine's Committees on Maternal and Child Health under Health Care Reform, Quality of Long-Term-Care Services in Home and Community-Based Settings, and Enhancing Federal Healthcare Quality Programs; the National Commission on Childhood Disability, and the Disability Policy Panel of the National Academy of Social Insurance (Chair, Children's Committee). He received a Robert Wood Johnson Foundation Investigator Award in Health Policy Research. He also served as a member of the Health Care Technology study section of the Agency for Health Care Policy and Research and of the National Advisory Council for the Agency for Healthcare Research and Quality.

Peter H. Bell

Peter Bell is the father of a 12 year old child with autism. Peter is currently the Executive Director and CEO of Cure Autism Now, one of the largest private funders of autism research in the world. Founded in 1995, Cure Autism Now is an organization of parents, clinicians and leading scientists committed to accelerating the pace of biomedical research in autism through research, education and outreach. Bell joined Cure Autism Now in 2004 following a successful 12-year marketing career at McNeil Consumer & Specialty Pharmaceuticals, a member of the Johnson & Johnson family of companies. Throughout his career, Bell developed and marketed a variety of pharmaceutical products including TYLENOL®, Children�s MOTRIN®, CONCERTA®, and RISPERDAL®. Bell is also very active within the autism community. He has served as the parent co-chair of the Research Committee for The Autism Center at UMDNJ and was a founding member of the Philadelphia Chapter of CAN. Bell and his family were also involved in the establishment of the M.I.N.D. Institute at UC, Davis. Peter and his wife, Liz, reside in Los Angeles, California with their three children.